News & Veranstaltungen

Succesful Day 1 at the Hashtag#DrugDeliverySummit in Frankfurt!! Top innovative presentations and insightful discussions during the networking session! Thank you for giving us the opportunity to present one of most innovative case studies. Reach out to Bernd S. or to Lia Martinez-Montero for additional information!

Are you a biotech enthusiast seeking cutting-edge solutions for your project? Join Conscio Group at BayOConnect 2024 in Munich on July 2-3! Meet Lia Martinez-Montero, BD Director of Conscio Pharma, and discover our comprehensive services for biosimilars and biologics. From precise analytics and clinical trials to batch release, Conscio Group offers full-spectrum support for your […]

Gen-Plus GmbH & Co. KG will be attending the European Drug Delivery Summit 2024 in Frankfurt on June 24-25. Our colleague Bernd S. will have the pleasure to give a talk at this renowned event. Stay tuned and reach out for additional information!

#IVPT  Have you been asked by the #Authorities to prove that your product is equivalent or non-inferior to the reference product? Are you interested in waiving #Bioequivalence for your topical product? Would you like to measure the permeation of the API in your innovative drug? Let´s discuss in-vitro penetration and permeation studies! #IVpermeation is relevant […]

Karin Cooke, PhD, Director Business Developer North America at Conscio Pharma Division, is one of the speakers at the live online training “Small Batches – Special Handling and Production” organized by ECA Foundation & ECA Academy. Karin will focus on personalized medicine, such as the production of intermediates for 2D and 3D printing, QC and testing […]

On September, 28 we had the pleasure to host the 6th Edition of Science Day by Gen-Plus at our facilities in Munich! 40 Attendees, 7 Speakers, tons of fun and insightful discussions on formulation, drug product development, innovation, Nitrosamines and Regulatory affairs. A big thank you to all our attendees for the participation, making Science […]